Lifevantage Corporation $LFVN Shares Sold by Ritholtz Wealth Management

Ritholtz Wealth Management reduced its stake in Lifevantage Corporation (NASDAQ:LFVN) by 21.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,662 shares of the company’s stock after selling 12,848 shares during the period. Ritholtz Wealth Management owned approximately 0.38% of Lifevantage worth $623,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of LFVN. Trexquant Investment LP acquired a new stake in Lifevantage in the 1st quarter valued at about $1,607,000. Acadian Asset Management LLC increased its stake in shares of Lifevantage by 47.3% during the first quarter. Acadian Asset Management LLC now owns 291,700 shares of the company’s stock worth $4,248,000 after buying an additional 93,661 shares during the period. Core Wealth Partners LLC acquired a new stake in Lifevantage in the first quarter valued at approximately $480,000. Cambridge Investment Research Advisors Inc. lifted its stake in Lifevantage by 23.2% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company’s stock worth $188,000 after acquiring an additional 2,421 shares during the last quarter. Finally, American Century Companies Inc. increased its position in shares of Lifevantage by 28.1% in the 1st quarter. American Century Companies Inc. now owns 122,428 shares of the company’s stock valued at $1,785,000 after purchasing an additional 26,876 shares during the last quarter. 35.32% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Michael A. Beindorff sold 4,125 shares of the stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $11.44, for a total transaction of $47,190.00. Following the completion of the sale, the director owned 22,858 shares in the company, valued at $261,495.52. This represents a 15.29% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 21.95% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on LFVN shares. Wall Street Zen cut shares of Lifevantage from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Weiss Ratings restated a “hold (c+)” rating on shares of Lifevantage in a research note on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.50.

Lifevantage Stock Down 1.8%

Shares of NASDAQ LFVN opened at $8.81 on Monday. The business has a 50-day moving average price of $11.35 and a 200 day moving average price of $12.37. The stock has a market cap of $111.80 million, a PE ratio of 11.91 and a beta of 0.26. Lifevantage Corporation has a 52-week low of $8.63 and a 52-week high of $27.38.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Thursday, September 4th. The company reported $0.17 EPS for the quarter, hitting the consensus estimate of $0.17. Lifevantage had a return on equity of 33.75% and a net margin of 4.29%.The company had revenue of $55.11 million for the quarter, compared to analyst estimates of $57.93 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. Lifevantage has set its FY 2026 guidance at 1.000-1.15 EPS.

Lifevantage Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 16th. Investors of record on Monday, September 8th were given a $0.045 dividend. The ex-dividend date was Monday, September 8th. This represents a $0.18 annualized dividend and a yield of 2.0%. Lifevantage’s dividend payout ratio is 24.32%.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.